Showing 1–15 of 15 results for author: Initiative, A d N

IGCN: Integrative Graph Convolutional Networks for Multi-modal Data

Authors: Cagri Ozdemir, Mohammad Al Olaimat, Yashu Vashishath, Serdar Bozdag, Alzheimer's Disease Neuroimaging Initiative

Abstract: Recent advances in Graph Neural Networks (GNN) have led to a considerable growth in graph data modeling for multi-modal data which contains various types of nodes and edges. Although some integrative prediction solutions have been developed recently for network-structured data, these methods have some restrictions. For a node classification task involving multi-modal data, certain data modalities… ▽ More Recent advances in Graph Neural Networks (GNN) have led to a considerable growth in graph data modeling for multi-modal data which contains various types of nodes and edges. Although some integrative prediction solutions have been developed recently for network-structured data, these methods have some restrictions. For a node classification task involving multi-modal data, certain data modalities may perform better when predicting one class, while others might excel in predicting a different class. Thus, to obtain a better learning representation, advanced computational methodologies are required for the integrative analysis of multi-modal data. Moreover, existing integrative tools lack a comprehensive and cohesive understanding of the rationale behind their specific predictions, making them unsuitable for enhancing model interpretability. Addressing these restrictions, we introduce a novel integrative neural network approach for multi-modal data networks, named Integrative Graph Convolutional Networks (IGCN). IGCN learns node embeddings from multiple topologies and fuses the multiple node embeddings into a weighted form by assigning attention coefficients to the node embeddings. Our proposed attention mechanism helps identify which types of data receive more emphasis for each sample to predict a certain class. Therefore, IGCN has the potential to unravel previously unknown characteristics within different node classification tasks. We benchmarked IGCN on several datasets from different domains, including a multi-omics dataset to predict cancer subtypes and a multi-modal clinical dataset to predict the progression of Alzheimer's disease. Experimental results show that IGCN outperforms or is on par with the state-of-the-art and baseline methods. △ Less

Submitted 4 February, 2024; v1 submitted 31 January, 2024; originally announced January 2024.

Transferring Models Trained on Natural Images to 3D MRI via Position Encoded Slice Models

Authors: Umang Gupta, Tamoghna Chattopadhyay, Nikhil Dhinagar, Paul M. Thompson, Greg Ver Steeg, The Alzheimer's Disease Neuroimaging Initiative

Abstract: Transfer learning has remarkably improved computer vision. These advances also promise improvements in neuroimaging, where training set sizes are often small. However, various difficulties arise in directly applying models pretrained on natural images to radiologic images, such as MRIs. In particular, a mismatch in the input space (2D images vs. 3D MRIs) restricts the direct transfer of models, of… ▽ More Transfer learning has remarkably improved computer vision. These advances also promise improvements in neuroimaging, where training set sizes are often small. However, various difficulties arise in directly applying models pretrained on natural images to radiologic images, such as MRIs. In particular, a mismatch in the input space (2D images vs. 3D MRIs) restricts the direct transfer of models, often forcing us to consider only a few MRI slices as input. To this end, we leverage the 2D-Slice-CNN architecture of Gupta et al. (2021), which embeds all the MRI slices with 2D encoders (neural networks that take 2D image input) and combines them via permutation-invariant layers. With the insight that the pretrained model can serve as the 2D encoder, we initialize the 2D encoder with ImageNet pretrained weights that outperform those initialized and trained from scratch on two neuroimaging tasks -- brain age prediction on the UK Biobank dataset and Alzheimer's disease detection on the ADNI dataset. Further, we improve the modeling capabilities of 2D-Slice models by incorporating spatial information through position embeddings, which can improve the performance in some cases. △ Less

Submitted 2 March, 2023; originally announced March 2023.

Comments: To appear at IEEE International Symposium on Biomedical Imaging 2023 (ISBI 2023). Code is available at https://github.com/umgupta/2d-slice-set-networks

Predicting Time-to-conversion for Dementia of Alzheimer's Type using Multi-modal Deep Survival Analysis

Authors: Ghazal Mirabnahrazam, Da Ma, Cédric Beaulac, Sieun Lee, Karteek Popuri, Hyunwoo Lee, Jiguo Cao, James E Galvin, Lei Wang, Mirza Faisal Beg, the Alzheimer's Disease Neuroimaging Initiative

Abstract: Dementia of Alzheimer's Type (DAT) is a complex disorder influenced by numerous factors, but it is unclear how each factor contributes to disease progression. An in-depth examination of these factors may yield an accurate estimate of time-to-conversion to DAT for patients at various disease stages. We used 401 subjects with 63 features from MRI, genetic, and CDC (Cognitive tests, Demographic, and… ▽ More Dementia of Alzheimer's Type (DAT) is a complex disorder influenced by numerous factors, but it is unclear how each factor contributes to disease progression. An in-depth examination of these factors may yield an accurate estimate of time-to-conversion to DAT for patients at various disease stages. We used 401 subjects with 63 features from MRI, genetic, and CDC (Cognitive tests, Demographic, and CSF) data modalities in the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. We used a deep learning-based survival analysis model that extends the classic Cox regression model to predict time-to-conversion to DAT. Our findings showed that genetic features contributed the least to survival analysis, while CDC features contributed the most. Combining MRI and genetic features improved survival prediction over using either modality alone, but adding CDC to any combination of features only worked as well as using only CDC features. Consequently, our study demonstrated that using the current clinical procedure, which includes gathering cognitive test results, can outperform survival analysis results produced using costly genetic or CSF data. △ Less

Submitted 2 May, 2022; originally announced May 2022.

Journal ref: Neurobiology of Aging, 121, (2023), 139-156

MRI-based Multi-task Decoupling Learning for Alzheimer's Disease Detection and MMSE Score Prediction: A Multi-site Validation

Authors: Xu Tian, ** Liu, Hulin Kuang, Yu Sheng, Jianxin Wang, The Alzheimer's Disease Neuroimaging Initiative

Abstract: Accurately detecting Alzheimer's disease (AD) and predicting mini-mental state examination (MMSE) score are important tasks in elderly health by magnetic resonance imaging (MRI). Most of the previous methods on these two tasks are based on single-task learning and rarely consider the correlation between them. Since the MMSE score, which is an important basis for AD diagnosis, can also reflect the… ▽ More Accurately detecting Alzheimer's disease (AD) and predicting mini-mental state examination (MMSE) score are important tasks in elderly health by magnetic resonance imaging (MRI). Most of the previous methods on these two tasks are based on single-task learning and rarely consider the correlation between them. Since the MMSE score, which is an important basis for AD diagnosis, can also reflect the progress of cognitive impairment, some studies have begun to apply multi-task learning methods to these two tasks. However, how to exploit feature correlation remains a challenging problem for these methods. To comprehensively address this challenge, we propose a MRI-based multi-task decoupled learning method for AD detection and MMSE score prediction. First, a multi-task learning network is proposed to implement AD detection and MMSE score prediction, which exploits feature correlation by adding three multi-task interaction layers between the backbones of the two tasks. Each multi-task interaction layer contains two feature decoupling modules and one feature interaction module. Furthermore, to enhance the generalization between tasks of the features selected by the feature decoupling module, we propose the feature consistency loss constrained feature decoupling module. Finally, in order to exploit the specific distribution information of MMSE score in different groups, a distribution loss is proposed to further enhance the model performance. We evaluate our proposed method on multi-site datasets. Experimental results show that our proposed multi-task decoupled representation learning method achieves good performance, outperforming single-task learning and other existing state-of-the-art methods. △ Less

Submitted 7 July, 2023; v1 submitted 2 April, 2022; originally announced April 2022.

Comments: There are some misstatements in the related work section of the paper. In the methods section, there are also errors in the description of some modules

DeepAD: A Robust Deep Learning Model of Alzheimer's Disease Progression for Real-World Clinical Applications

Authors: Somaye Hashemifar, Claudia Iriondo, Evan Casey, Mohsen Hejrati, for Alzheimer's Disease Neuroimaging Initiative

Abstract: The ability to predict the future trajectory of a patient is a key step toward the development of therapeutics for complex diseases such as Alzheimer's disease (AD). However, most machine learning approaches developed for prediction of disease progression are either single-task or single-modality models, which can not be directly adopted to our setting involving multi-task learning with high dimen… ▽ More The ability to predict the future trajectory of a patient is a key step toward the development of therapeutics for complex diseases such as Alzheimer's disease (AD). However, most machine learning approaches developed for prediction of disease progression are either single-task or single-modality models, which can not be directly adopted to our setting involving multi-task learning with high dimensional images. Moreover, most of those approaches are trained on a single dataset (i.e. cohort), which can not be generalized to other cohorts. We propose a novel multimodal multi-task deep learning model to predict AD progression by analyzing longitudinal clinical and neuroimaging data from multiple cohorts. Our proposed model integrates high dimensional MRI features from a 3D convolutional neural network with other data modalities, including clinical and demographic information, to predict the future trajectory of patients. Our model employs an adversarial loss to alleviate the study-specific imaging bias, in particular the inter-study domain shifts. In addition, a Sharpness-Aware Minimization (SAM) optimization technique is applied to further improve model generalization. The proposed model is trained and tested on various datasets in order to evaluate and validate the results. Our results showed that 1) our model yields significant improvement over the baseline models, and 2) models using extracted neuroimaging features from 3D convolutional neural network outperform the same models when applied to MRI-derived volumetric features. △ Less

Submitted 7 September, 2023; v1 submitted 17 March, 2022; originally announced March 2022.

Machine Learning Based Multimodal Neuroimaging Genomics Dementia Score for Predicting Future Conversion to Alzheimer's Disease

Authors: Ghazal Mirabnahrazam, Da Ma, Sieun Lee, Karteek Popuri, Hyunwoo Lee, Jiguo Cao, Lei Wang, James E Galvin, Mirza Faisal Beg, the Alzheimer's Disease Neuroimaging Initiative

Abstract: Background: The increasing availability of databases containing both magnetic resonance imaging (MRI) and genetic data allows researchers to utilize multimodal data to better understand the characteristics of dementia of Alzheimer's type (DAT). Objective: The goal of this study was to develop and analyze novel biomarkers that can help predict the development and progression of DAT. Methods: We use… ▽ More Background: The increasing availability of databases containing both magnetic resonance imaging (MRI) and genetic data allows researchers to utilize multimodal data to better understand the characteristics of dementia of Alzheimer's type (DAT). Objective: The goal of this study was to develop and analyze novel biomarkers that can help predict the development and progression of DAT. Methods: We used feature selection and ensemble learning classifier to develop an image/genotype-based DAT score that represents a subject's likelihood of develo** DAT in the future. Three feature types were used: MRI only, genetic only, and combined multimodal data. We used a novel data stratification method to better represent different stages of DAT. Using a pre-defined 0.5 threshold on DAT scores, we predicted whether or not a subject would develop DAT in the future. Results: Our results on Alzheimer's Disease Neuroimaging Initiative (ADNI) database showed that dementia scores using genetic data could better predict future DAT progression for currently normal control subjects (Accuracy=0.857) compared to MRI (Accuracy=0.143), while MRI can better characterize subjects with stable mild cognitive impairment (Accuracy=0.614) compared to genetics (Accuracy=0.356). Combining MRI and genetic data showed improved classification performance in the remaining stratified groups. Conclusion: MRI and genetic data can contribute to DAT prediction in different ways. MRI data reflects anatomical changes in the brain, while genetic data can detect the risk of DAT progression prior to the symptomatic onset. Combining information from multimodal data in the right way can improve prediction performance. △ Less

Submitted 10 March, 2022; originally announced March 2022.

Journal ref: J Alzheimers Dis 1 Jan. (2022) 1-21

Revisiting convolutional neural network on graphs with polynomial approximations of Laplace-Beltrami spectral filtering

Authors: Shih-Gu Huang, Moo K. Chung, Anqi Qiu, Alzheimer's Disease Neuroimaging Initiative

Abstract: This paper revisits spectral graph convolutional neural networks (graph-CNNs) given in Defferrard (2016) and develops the Laplace-Beltrami CNN (LB-CNN) by replacing the graph Laplacian with the LB operator. We then define spectral filters via the LB operator on a graph. We explore the feasibility of Chebyshev, Laguerre, and Hermite polynomials to approximate LB-based spectral filters and define an… ▽ More This paper revisits spectral graph convolutional neural networks (graph-CNNs) given in Defferrard (2016) and develops the Laplace-Beltrami CNN (LB-CNN) by replacing the graph Laplacian with the LB operator. We then define spectral filters via the LB operator on a graph. We explore the feasibility of Chebyshev, Laguerre, and Hermite polynomials to approximate LB-based spectral filters and define an update of the LB operator for pooling in the LBCNN. We employ the brain image data from Alzheimer's Disease Neuroimaging Initiative (ADNI) and demonstrate the use of the proposed LB-CNN. Based on the cortical thickness of the ADNI dataset, we showed that the LB-CNN didn't improve classification accuracy compared to the spectral graph-CNN. The three polynomials had a similar computational cost and showed comparable classification accuracy in the LB-CNN or spectral graph-CNN. Our findings suggest that even though the shapes of the three polynomials are different, deep learning architecture allows us to learn spectral filters such that the classification performance is not dependent on the type of the polynomials or the operators (graph Laplacian and LB operator). △ Less

Submitted 25 October, 2020; originally announced October 2020.

Fast Mesh Data Augmentation via Chebyshev Polynomial of Spectral filtering

Authors: Shih-Gu Huang, Moo K. Chung, Anqi Qiu, Alzheimer's Disease Neuroimaging Initiative

Abstract: Deep neural networks have recently been recognized as one of the powerful learning techniques in computer vision and medical image analysis. Trained deep neural networks need to be generalizable to new data that was not seen before. In practice, there is often insufficient training data available and augmentation is used to expand the dataset. Even though graph convolutional neural network (graph-… ▽ More Deep neural networks have recently been recognized as one of the powerful learning techniques in computer vision and medical image analysis. Trained deep neural networks need to be generalizable to new data that was not seen before. In practice, there is often insufficient training data available and augmentation is used to expand the dataset. Even though graph convolutional neural network (graph-CNN) has been widely used in deep learning, there is a lack of augmentation methods to generate data on graphs or surfaces. This study proposes two unbiased augmentation methods, Laplace-Beltrami eigenfunction Data Augmentation (LB-eigDA) and Chebyshev polynomial Data Augmentation (C-pDA), to generate new data on surfaces, whose mean is the same as that of real data. LB-eigDA augments data via the resampling of the LB coefficients. In parallel with LB-eigDA, we introduce a fast augmentation approach, C-pDA, that employs a polynomial approximation of LB spectral filters on surfaces. We design LB spectral bandpass filters by Chebyshev polynomial approximation and resample signals filtered via these filters to generate new data on surfaces. We first validate LB-eigDA and C-pDA via simulated data and demonstrate their use for improving classification accuracy. We then employ the brain images of Alzheimer's Disease Neuroimaging Initiative (ADNI) and extract cortical thickness that is represented on the cortical surface to illustrate the use of the two augmentation methods. We demonstrate that augmented cortical thickness has a similar pattern to real data. Second, we show that C-pDA is much faster than LB-eigDA. Last, we show that C-pDA can improve the AD classification accuracy of graph-CNN. △ Less

Submitted 6 October, 2020; originally announced October 2020.

GANDALF: Generative Adversarial Networks with Discriminator-Adaptive Loss Fine-tuning for Alzheimer's Disease Diagnosis from MRI

Authors: Hoo-Chang Shin, Alvin Ihsani, Ziyue Xu, Swetha Mandava, Sharath Turuvekere Sreenivas, Christopher Forster, Jiook Cha, Alzheimer's Disease Neuroimaging Initiative

Abstract: Positron Emission Tomography (PET) is now regarded as the gold standard for the diagnosis of Alzheimer's Disease (AD). However, PET imaging can be prohibitive in terms of cost and planning, and is also among the imaging techniques with the highest dosage of radiation. Magnetic Resonance Imaging (MRI), in contrast, is more widely available and provides more flexibility when setting the desired imag… ▽ More Positron Emission Tomography (PET) is now regarded as the gold standard for the diagnosis of Alzheimer's Disease (AD). However, PET imaging can be prohibitive in terms of cost and planning, and is also among the imaging techniques with the highest dosage of radiation. Magnetic Resonance Imaging (MRI), in contrast, is more widely available and provides more flexibility when setting the desired image resolution. Unfortunately, the diagnosis of AD using MRI is difficult due to the very subtle physiological differences between healthy and AD subjects visible on MRI. As a result, many attempts have been made to synthesize PET images from MR images using generative adversarial networks (GANs) in the interest of enabling the diagnosis of AD from MR. Existing work on PET synthesis from MRI has largely focused on Conditional GANs, where MR images are used to generate PET images and subsequently used for AD diagnosis. There is no end-to-end training goal. This paper proposes an alternative approach to the aforementioned, where AD diagnosis is incorporated in the GAN training objective to achieve the best AD classification performance. Different GAN lossesare fine-tuned based on the discriminator performance, and the overall training is stabilized. The proposed network architecture and training regime show state-of-the-art performance for three- and four- class AD classification tasks. △ Less

Submitted 10 August, 2020; originally announced August 2020.

Comments: Accepted for publication at the MICCAI 2020 conference

GANBERT: Generative Adversarial Networks with Bidirectional Encoder Representations from Transformers for MRI to PET synthesis

Authors: Hoo-Chang Shin, Alvin Ihsani, Swetha Mandava, Sharath Turuvekere Sreenivas, Christopher Forster, Jiook Cha, Alzheimer's Disease Neuroimaging Initiative

Abstract: Synthesizing medical images, such as PET, is a challenging task due to the fact that the intensity range is much wider and denser than those in photographs and digital renderings and are often heavily biased toward zero. Above all, intensity values in PET have absolute significance, and are used to compute parameters that are reproducible across the population. Yet, usually much manual adjustment… ▽ More Synthesizing medical images, such as PET, is a challenging task due to the fact that the intensity range is much wider and denser than those in photographs and digital renderings and are often heavily biased toward zero. Above all, intensity values in PET have absolute significance, and are used to compute parameters that are reproducible across the population. Yet, usually much manual adjustment has to be made in pre-/post- processing when synthesizing PET images, because its intensity ranges can vary a lot, e.g., between -100 to 1000 in floating point values. To overcome these challenges, we adopt the Bidirectional Encoder Representations from Transformers (BERT) algorithm that has had great success in natural language processing (NLP), where wide-range floating point intensity values are represented as integers ranging between 0 to 10000 that resemble a dictionary of natural language vocabularies. BERT is then trained to predict a proportion of masked values images, where its "next sentence prediction (NSP)" acts as GAN discriminator. Our proposed approach, is able to generate PET images from MRI images in wide intensity range, with no manual adjustments in pre-/post- processing. It is a method that can scale and ready to deploy. △ Less

Submitted 10 August, 2020; originally announced August 2020.

An Optimized PatchMatch for Multi-scale and Multi-feature Label Fusion

Authors: Rémi Giraud, Vinh-Thong Ta, Nicolas Papadakis, José V. Manjón, D. Louis Collins, Pierrick Coupé, Alzheimer's Disease Neuroimaging Initiative

Abstract: Automatic segmentation methods are important tools for quantitative analysis of Magnetic Resonance Images (MRI). Recently, patch-based label fusion approaches have demonstrated state-of-the-art segmentation accuracy. In this paper, we introduce a new patch-based label fusion framework to perform segmentation of anatomical structures. The proposed approach uses an Optimized PAtchMatch Label fusion… ▽ More Automatic segmentation methods are important tools for quantitative analysis of Magnetic Resonance Images (MRI). Recently, patch-based label fusion approaches have demonstrated state-of-the-art segmentation accuracy. In this paper, we introduce a new patch-based label fusion framework to perform segmentation of anatomical structures. The proposed approach uses an Optimized PAtchMatch Label fusion (OPAL) strategy that drastically reduces the computation time required for the search of similar patches. The reduced computation time of OPAL opens the way for new strategies and facilitates processing on large databases. In this paper, we investigate new perspectives offered by OPAL, by introducing a new multi-scale and multi-feature framework. During our validation on hippocampus segmentation we use two datasets: young adults in the ICBM cohort and elderly adults in the EADC-ADNI dataset. For both, OPAL is compared to state-of-the-art methods. Results show that OPAL obtained the highest median Dice coefficient (89.9% for ICBM and 90.1% for EADC-ADNI). Moreover, in both cases, OPAL produced a segmentation accuracy similar to inter-expert variability. On the EADC-ADNI dataset, we compare the hippocampal volumes obtained by manual and automatic segmentation. The volumes appear to be highly correlated that enables to perform more accurate separation of pathological populations. △ Less

Submitted 17 March, 2019; originally announced March 2019.

Comments: Neuroimage 2016

Diagnosis of Alzheimer's Disease via Multi-modality 3D Convolutional Neural Network

Authors: Yechong Huang, Jiahang Xu, Yuncheng Zhou, Tong Tong, Xiahai Zhuang, the Alzheimer's Disease Neuroimaging Initiative

Abstract: Alzheimer's Disease (AD) is one of the most concerned neurodegenerative diseases. In the last decade, studies on AD diagnosis attached great significance to artificial intelligence (AI)-based diagnostic algorithms. Among the diverse modality imaging data, T1-weighted MRI and 18F-FDGPET are widely researched for this task. In this paper, we propose a novel convolutional neural network (CNN) to fuse… ▽ More Alzheimer's Disease (AD) is one of the most concerned neurodegenerative diseases. In the last decade, studies on AD diagnosis attached great significance to artificial intelligence (AI)-based diagnostic algorithms. Among the diverse modality imaging data, T1-weighted MRI and 18F-FDGPET are widely researched for this task. In this paper, we propose a novel convolutional neural network (CNN) to fuse the multi-modality information including T1-MRI and FDG-PDT images around the hippocampal area for the diagnosis of AD. Different from the traditional machine learning algorithms, this method does not require manually extracted features, and utilizes the stateof-art 3D image-processing CNNs to learn features for the diagnosis and prognosis of AD. To validate the performance of the proposed network, we trained the classifier with paired T1-MRI and FDG-PET images using the ADNI datasets, including 731 Normal (NL) subjects, 647 AD subjects, 441 stable MCI (sMCI) subjects and 326 progressive MCI (pMCI) subjects. We obtained the maximal accuracies of 90.10% for NL/AD task, 87.46% for NL/pMCI task, and 76.90% for sMCI/pMCI task. The proposed framework yields comparative results against state-of-the-art approaches. Moreover, the experimental results have demonstrated that (1) segmentation is not a prerequisite by using CNN, (2) the hippocampal area provides enough information to give a reference to AD diagnosis. Keywords: Alzheimer's Disease, Multi-modality, Image Classification, CNN, Deep Learning, Hippocampal △ Less

Submitted 26 February, 2019; originally announced February 2019.

Comments: 21 pages, 5 figures, 9 tables

Journal ref: https://www.frontiersin.org/articles/10.3389/fnins.2019.00509/full

Neuroimaging Modality Fusion in Alzheimer's Classification Using Convolutional Neural Networks

Authors: Arjun Punjabi, Adam Martersteck, Yanran Wang, Todd B. Parrish, Aggelos K. Katsaggelos, the Alzheimer's Disease Neuroimaging Initiative

Abstract: Automated methods for Alzheimer's disease (AD) classification have the potential for great clinical benefits and may provide insight for combating the disease. Machine learning, and more specifically deep neural networks, have been shown to have great efficacy in this domain. These algorithms often use neurological imaging data such as MRI and PET, but a comprehensive and balanced comparison of th… ▽ More Automated methods for Alzheimer's disease (AD) classification have the potential for great clinical benefits and may provide insight for combating the disease. Machine learning, and more specifically deep neural networks, have been shown to have great efficacy in this domain. These algorithms often use neurological imaging data such as MRI and PET, but a comprehensive and balanced comparison of these modalities has not been performed. In order to accurately determine the relative strength of each imaging variant, this work performs a comparison study in the context of Alzheimer's dementia classification using the Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. Furthermore, this work analyzes the benefits of using both modalities in a fusion setting and discusses how these data types may be leveraged in future AD studies using deep learning. △ Less

Submitted 12 November, 2018; originally announced November 2018.

Development and validation of a novel dementia of Alzheimer's type (DAT) score based on metabolism FDG-PET imaging

Authors: Karteek Popuri, Rakesh Balachandar, Kathryn Alpert, Donghuan Lu, Mahadev Bhalla, Ian Mackenzie, Robin Ging-Yuek Hsiung, Lei Wang, Mirza Faisal Beg, the Alzhemier's Disease Neuroimaging Initiative

Abstract: Fluorodeoxyglucose positron emission tomography (FDG-PET) imaging based 3D topographic brain glucose metabolism patterns from normal controls (NC) and individuals with dementia of Alzheimer's type (DAT) are used to train a novel multi-scale ensemble classification model. This ensemble model outputs a FDG-PET DAT score (FPDS) between 0 and 1 denoting the probability of a subject to be clinically di… ▽ More Fluorodeoxyglucose positron emission tomography (FDG-PET) imaging based 3D topographic brain glucose metabolism patterns from normal controls (NC) and individuals with dementia of Alzheimer's type (DAT) are used to train a novel multi-scale ensemble classification model. This ensemble model outputs a FDG-PET DAT score (FPDS) between 0 and 1 denoting the probability of a subject to be clinically diagnosed with DAT based on their metabolism profile. A novel 7 group image stratification scheme is devised that groups images not only based on their associated clinical diagnosis but also on past and future trajectories of the clinical diagnoses, yielding a more continuous representation of the different stages of DAT spectrum that mimics a real-world clinical setting. The potential for using FPDS as a DAT biomarker was validated on a large number of FDG-PET images (N=2984) obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database taken across the proposed stratification, and a good classification AUC (area under the curve) of 0.78 was achieved in distinguishing between images belonging to subjects on a DAT trajectory and those images taken from subjects not progressing to a DAT diagnosis. Further, the FPDS biomarker achieved state-of-the-art performance on the mild cognitive impairment (MCI) to DAT conversion prediction task with an AUC of 0.81, 0.80, 0.77 for the 2, 3, 5 years to conversion windows respectively. △ Less

Submitted 2 November, 2017; originally announced November 2017.

Multiple Kernel Learning and Automatic Subspace Relevance Determination for High-dimensional Neuroimaging Data

Authors: Murat Seckin Ayhan, Vijay Raghavan, Alzheimer's disease Neuroimaging Initiative

Abstract: Alzheimer's disease is a major cause of dementia. Its diagnosis requires accurate biomarkers that are sensitive to disease stages. In this respect, we regard probabilistic classification as a method of designing a probabilistic biomarker for disease staging. Probabilistic biomarkers naturally support the interpretation of decisions and evaluation of uncertainty associated with them. In this paper,… ▽ More Alzheimer's disease is a major cause of dementia. Its diagnosis requires accurate biomarkers that are sensitive to disease stages. In this respect, we regard probabilistic classification as a method of designing a probabilistic biomarker for disease staging. Probabilistic biomarkers naturally support the interpretation of decisions and evaluation of uncertainty associated with them. In this paper, we obtain probabilistic biomarkers via Gaussian Processes. Gaussian Processes enable probabilistic kernel machines that offer flexible means to accomplish Multiple Kernel Learning. Exploiting this flexibility, we propose a new variation of Automatic Relevance Determination and tackle the challenges of high dimensionality through multiple kernels. Our research results demonstrate that the Gaussian Process models are competitive with or better than the well-known Support Vector Machine in terms of classification performance even in the cases of single kernel learning. Extending the basic scheme towards the Multiple Kernel Learning, we improve the efficacy of the Gaussian Process models and their interpretability in terms of the known anatomical correlates of the disease. For instance, the disease pathology starts in and around the hippocampus and entorhinal cortex. Through the use of Gaussian Processes and Multiple Kernel Learning, we have automatically and efficiently determined those portions of neuroimaging data. In addition to their interpretability, our Gaussian Process models are competitive with recent deep learning solutions under similar settings. △ Less

Submitted 2 June, 2017; originally announced June 2017.

Comments: The material presented here is to promote the dissemination of scholarly and technical work in a timely fashion. Data in this article are from ADNI (adni.loni.usc.edu). As such, ADNI provided data but did not participate in writing of this report